SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-23-034690
Filing Date
2023-10-19
Accepted
2023-10-19 16:06:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A avtx-additionalmaterialsdea.htm DEFA14A 12925
2 GRAPHIC noticecard_avalotherapeu001.jpg GRAPHIC 156758
3 GRAPHIC noticecard_avalotherapeu002.jpg GRAPHIC 114767
  Complete submission text file 0001628280-23-034690.txt   388170
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37590 | Film No.: 231334802
SIC: 2834 Pharmaceutical Preparations